Skip to main content
Clinical Trials/CTRI/2023/05/052423
CTRI/2023/05/052423Not yet recruitingPhase 2

A PROSPECTIVE OPEN LABELLED, SINGLE ARM, NON-RANDOMIZED, SINGLE CENTRIC, PHASE II CLINICAL TRIAL TO DETERMINE THE EFFECTIVENESS OF THOTTAR CHINUNGI CHOORANAM IN THE MANAGEMENT OF MADHUMEGA NOI (DIABETES MELLITUS

Government Siddha Medical College and Hospital0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1.Patients with symptoms of polyuria, polydipsia, polyphagia,asthenia, nocturia, obesity(metabolic syndrome),numbness,tingling sensation,mood changes and irritability difficulty in concentration.
  • •2.Even if patients is having any one among the three (WHO criteria 2019)
  • •a. FBS >126mg/dl and <250 mg/dl or
  • •b. PBS >200 mg/dl and <350 mg/dl or
  • •c. HbA1c >6.5 and <10

Exclusion Criteria

  • •1.Age below 34 years and above 60 years
  • •2.Type I diabetes mellitus
  • •3.Gestational diabetes
  • •4.Diabetes insipidus
  • •5.Pregnancy
  • •6.Lactating mother
  • •7.Chronic kidney disease
  • •7.Ischemic heart disease

Investigators

Sponsor
Government Siddha Medical College and Hospital

Similar Trials